Enerpac Tool
EPAC
Precision Drilling
PDS
Workday
WDAY
eBay
EBAY
Halozyme Therapeutics
HALO
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 9.03%1.26B | -25.09%221.91M | 14.46%314.27M | 23.71%371.45M | 23.95%349.87M | 35.94%1.15B | 31.17%296.25M | 33.57%274.57M | 49.01%300.26M | 30.96%282.28M |
Operating revenue | 9.03%1.26B | -25.09%221.91M | 14.46%314.27M | 23.71%371.45M | 23.95%349.87M | 35.94%1.15B | 31.17%296.25M | 33.57%274.57M | 49.01%300.26M | 30.96%282.28M |
Cost of revenue | 8.51%1.09B | -26.85%188.45M | 17.50%272.25M | 23.06%320.37M | 21.35%305.63M | 30.74%1B | 28.59%257.61M | 27.04%231.7M | 42.16%260.34M | 25.80%251.86M |
Gross profit | 12.48%170.81M | -13.41%33.46M | -1.96%42.03M | 27.92%51.08M | 45.45%44.24M | 84.25%151.85M | 51.38%38.64M | 84.94%42.87M | 117.31%39.93M | 98.29%30.42M |
Operating expense | 18.11%86.32M | 20.25%19.68M | 15.57%22.33M | 16.90%22.77M | 20.19%21.54M | 38.35%73.09M | 24.77%16.37M | 31.66%19.32M | 53.98%19.48M | 44.71%17.92M |
Selling and administrative expenses | 18.11%86.32M | 20.25%19.68M | 15.57%22.33M | 16.90%22.77M | 20.19%21.54M | 38.35%73.09M | 24.77%16.37M | 31.66%19.32M | 53.98%19.48M | 44.71%17.92M |
Operating profit | 7.26%84.48M | -38.14%13.78M | -16.35%19.7M | 38.42%28.31M | 81.70%22.7M | 166.18%78.77M | 79.51%22.27M | 176.83%23.55M | 257.31%20.45M | 322.92%12.49M |
Net non-operating interest income expense | 34.25%-3.93M | 73.50%-384K | 86.16%-251K | -20.47%-2.05M | -23.02%-1.25M | -76.80%-5.97M | -12.24%-1.45M | -73.99%-1.81M | -170.70%-1.7M | -142.11%-1.01M |
Non-operating interest expense | -34.25%3.93M | -73.50%384K | -86.16%251K | 20.47%2.05M | 23.02%1.25M | 76.80%5.97M | 12.24%1.45M | 73.99%1.81M | 170.70%1.7M | 142.11%1.01M |
Other net income (expense) | -142.89%-425K | -614.09%-766K | 9.18%321K | -105.68%-13K | -89.62%33K | 306.03%991K | -70.90%149K | 144.14%294K | 183.27%229K | 711.54%318K |
Other non- operating income (expenses) | -142.89%-425K | -614.09%-766K | 9.18%321K | -105.68%-13K | -89.62%33K | 306.03%991K | -70.90%149K | 144.14%294K | 183.27%229K | 711.54%318K |
Income before tax | 8.60%80.13M | -39.79%12.63M | -10.26%19.77M | 38.29%26.24M | 82.12%21.49M | 186.74%73.78M | 80.36%20.97M | 224.03%22.03M | 293.73%18.98M | 375.00%11.8M |
Income tax | 7.38%16.64M | -51.02%2.1M | -4.97%4.35M | 41.03%5.73M | 73.13%4.47M | 187.65%15.49M | 83.10%4.28M | 191.77%4.57M | 282.22%4.06M | 515.51%2.58M |
Net income | 8.93%63.49M | -36.92%10.53M | -11.65%15.43M | 37.54%20.51M | 84.63%17.02M | 186.50%58.29M | 79.67%16.7M | 233.70%17.46M | 296.99%14.92M | 346.49%9.22M |
Net income continuous Operations | 8.93%63.49M | -36.92%10.53M | -11.65%15.43M | 37.54%20.51M | 84.63%17.02M | 186.50%58.29M | 79.67%16.7M | 233.70%17.46M | 296.99%14.92M | 346.49%9.22M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 8.93%63.49M | -36.92%10.53M | -11.65%15.43M | 37.54%20.51M | 84.63%17.02M | 186.50%58.29M | 79.67%16.7M | 233.70%17.46M | 296.99%14.92M | 346.49%9.22M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 8.93%63.49M | -36.92%10.53M | -11.65%15.43M | 37.54%20.51M | 84.63%17.02M | 186.50%58.29M | 79.67%16.7M | 233.70%17.46M | 296.99%14.92M | 346.49%9.22M |
Basic earnings per share | 8.82%5.55 | -36.99%0.92 | -11.76%1.35 | 37.69%1.79 | 83.95%1.49 | 186.52%5.1 | 80.25%1.46 | 232.61%1.53 | 293.94%1.3 | 350.00%0.81 |
Diluted earnings per share | 7.89%5.47 | -37.24%0.91 | -12.50%1.33 | 37.98%1.78 | 81.48%1.47 | 184.83%5.07 | 79.01%1.45 | 230.43%1.52 | 290.91%1.29 | 350.00%0.81 |
Dividend per share | 5.56%0.76 | 5.56%0.19 | 5.56%0.19 | 5.56%0.19 | 5.56%0.19 | 0.00%0.72 | 0.00%0.18 | 0.00%0.18 | 0.00%0.18 | 0.00%0.18 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |